Astrana Health, Inc. reiterated earnings guidance for the year ending December 31, 2024. For the year, the company expects total revenue in the range of $1,650.0 million to $1,850.0 million, Net income attributable to Astrana Health, Inc. in the range of $61.0 million to $73.0 million and EPS ? diluted in the range of $1.28 to $1.52.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.06 USD | +3.63% | -4.63% | +1.84% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.84% | 184.28Cr | |
+17.83% | 8.26TCr | |
-28.98% | 6.99TCr | |
0.00% | 2.65TCr | |
+3.06% | 1.73TCr | |
-13.03% | 1.66TCr | |
+2.13% | 1.56TCr | |
+74.63% | 1.32TCr | |
+1.18% | 1.27TCr | |
+73.90% | 1.26TCr |
- Stock Market
- Equities
- ASTH Stock
- News Astrana Health, Inc.
- Astrana Health, Inc. Reiterates Earnings Guidance for the Year Ending December 31, 2024